- Home
- RVPH vs ALAR Comparison
RVPH vs ALAR Comparison
Compare RVPH & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ALAR
- Stock Information
- Founded
- RVPH 2006
- ALAR 2013
- Country
- RVPH United States
- ALAR Israel
- Employees
- RVPH N/A
- ALAR N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ALAR Computer Software: Prepackaged Software
- Sector
- RVPH Health Care
- ALAR Technology
- Exchange
- RVPH Nasdaq
- ALAR Nasdaq
- Market Cap
- RVPH 88.0M
- ALAR 94.0M
- IPO Year
- RVPH N/A
- ALAR 2018
- Fundamental
- Price
- RVPH $1.40
- ALAR $6.90
- Analyst Decision
- RVPH Strong Buy
- ALAR Strong Buy
- Analyst Count
- RVPH 5
- ALAR 2
- Target Price
- RVPH $11.40
- ALAR $24.00
- AVG Volume (30 Days)
- RVPH 1.4M
- ALAR 115.1K
- Earning Date
- RVPH 04-14-2025
- ALAR 03-13-2025
- Dividend Yield
- RVPH N/A
- ALAR N/A
- EPS Growth
- RVPH N/A
- ALAR N/A
- EPS
- RVPH N/A
- ALAR 0.10
- Revenue
- RVPH N/A
- ALAR $31,561,000.00
- Revenue This Year
- RVPH N/A
- ALAR $22.82
- Revenue Next Year
- RVPH N/A
- ALAR $9.87
- P/E Ratio
- RVPH N/A
- ALAR $7.59
- Revenue Growth
- RVPH N/A
- ALAR 40.80
- 52 Week Low
- RVPH $0.60
- ALAR $6.78
- 52 Week High
- RVPH $4.33
- ALAR $46.69
- Technical
- Relative Strength Index (RSI)
- RVPH 31.30
- ALAR 17.35
- Support Level
- RVPH $1.36
- ALAR $6.78
- Resistance Level
- RVPH $1.88
- ALAR $8.50
- Average True Range (ATR)
- RVPH 0.15
- ALAR 0.50
- MACD
- RVPH -0.06
- ALAR -0.24
- Stochastic Oscillator
- RVPH 7.59
- ALAR 3.13
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.